By Dean Seal
Crinetics Pharmaceuticals said it has hired the chief financial officer of Revance Therapeutics to replace its outgoing finance chief.
The clinical-stage pharmaceutical company said Monday that Tobin Schilke will join the C-suite at the end of the month.
Prior to Revance, Schilke was the CFO of Achaogen and had stints at Roche and Genentech before that.
Crinetics said back in August that Marc Wilson was departing as CFO for personal reasons.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
February 24, 2025 08:50 ET (13:50 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.